NRG GY005 Cediranib Maleate and Olaparib or Standard Chemotherapy in Treating Patients With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

July 16, 2018
https://clinicaltrials.gov/ct2/show/NCT02502266
Cancer - Gynecologic/ Ovarian
Principal Investigator: Rabbie K Hanna, MD
GYNECOLOGY, CANCER, FALLOPIAN TUBE, OVARIAN, PERITONEAL, RECURRENT, REFRACTORY
Open